about
Nonmedical prescription stimulant use among college students: why we need to do something and what we need to do.Prescription opioid abuse, pain and addiction: clinical issues and implicationsAssessment of a formulation designed to be crush-resistant in prescription opioid abusers.A comparison among tapentadol tamper-resistant formulations (TRF) and OxyContin® (non-TRF) in prescription opioid abusers.Prescription drug abuse: an epidemic dilemma.Kitchen chemistry: A scoping review of the diversionary use of pharmaceuticals for non-medicinal use and home production of drug solutions.Designing a tool allowing for a standardized assessment of resistance to drug diversion.Comorbidity and "self-medication".
P2860
Q34183633-E9F858C6-A0EB-4416-A490-3857B2A8EFEDQ34223553-D3D1010E-2FAD-409D-9ADF-C80447586326Q36845718-A2AA93C1-8872-4649-8DC3-DA0EBE4BABF6Q36878938-ADF5A43A-D434-4509-9443-C2FB5E986E61Q37774619-6448677F-E973-41FE-BD98-879136939E8EQ38195230-0F20FDE1-BF90-4196-9B0B-064D9DBEBAD3Q43317466-5EEEC871-8219-4C8C-80A0-1054ADDBCE38Q46089750-E36EDFD8-B29C-45BF-B785-841F1D2B79A2
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Can drug design inhibit abuse?
@ast
Can drug design inhibit abuse?
@en
type
label
Can drug design inhibit abuse?
@ast
Can drug design inhibit abuse?
@en
prefLabel
Can drug design inhibit abuse?
@ast
Can drug design inhibit abuse?
@en
P2093
P2860
P1476
Can drug design inhibit abuse?
@en
P2093
David E Smith
John J Coleman
Mark S Gold
Peter B Bensinger
Robert L DuPont
Robert P Bianchi
P2860
P304
P356
10.1080/02791072.2005.10399808
P577
2005-12-01T00:00:00Z